Profile data is unavailable for this security.
About the company
Laboratorio Farmaceutico Erfo SpA is an Italy-based pharmaceutical company primarily engaged in the nutraceutical sector. The Company specializes in the production of nutritional supplements, that thanks to research and development carried out internally and in collaboration with the University Campus Bio-Medico of Rome and the University of Messina provides products with a scientific value in different therapeutic areas. The Company operates globally.
- Revenue in EUR (TTM)5.74m
- Net income in EUR553.82k
- Incorporated2010
- Employees33.00
- LocationLaboratorio Farmaceutico Erfo SpAViale Geki RussoZona Artigianale Loc. PontegalloVILLAFRANCA TIRRENA 98049ItalyITA
- Websitehttps://www.erfo.it/
More ▼
Peer analysis
Key Information
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Calmer Co International Ltd | 1.51m | -2.77m | 9.26m | -- | -- | -- | -- | 6.11 | -0.0083 | -0.0083 | 0.0039 | -0.0005 | 0.655 | 1.34 | 9.62 | -- | -119.81 | -139.15 | -231.33 | -198.55 | 36.03 | 30.26 | -182.94 | -388.81 | 0.482 | -9.36 | 1.22 | -- | -13.00 | 239.43 | 11.40 | -- | -- | -- |
| Oncimmune Holdings PLC | 1.44m | -3.80m | 9.48m | 56.00 | -- | -- | -- | 6.57 | -0.0427 | 0.0939 | 0.0163 | -0.0172 | 0.1756 | 1.19 | 0.6917 | -- | -46.21 | -- | -- | -- | 63.34 | -- | -263.10 | -- | 1.01 | -0.6815 | 1.32 | -- | -- | -- | -- | -- | -- | -- |
| Tonix Pharmaceuticals Holding Corp | 9.37m | -90.13m | 9.51m | 103.00 | -- | 0.0127 | -- | 1.01 | -177.41 | -177.41 | 9.46 | 46.94 | 0.0652 | -- | -- | 99,514.56 | -62.71 | -59.46 | -70.20 | -65.92 | 37.55 | -- | -961.87 | -5,126.73 | 0.8666 | -- | 0.0767 | -- | -- | -- | 0.1874 | -- | 320.57 | -- |
| Laboratorio Farmaceutico Erfo SpA | 5.74m | 553.82k | 9.81m | 33.00 | 17.24 | 1.19 | 7.49 | 1.71 | 0.0632 | 0.0632 | 0.6594 | 0.914 | 0.5548 | 3.44 | 11.55 | 173,850.30 | 5.71 | 13.40 | 6.99 | 16.76 | 41.94 | 51.81 | 10.29 | 21.01 | 1.37 | 30.93 | 0.0557 | -- | 24.06 | 8.62 | -22.66 | -13.88 | -- | -- |
| TrivarX Ltd | 12.80k | -2.30m | 9.84m | 4.00 | -- | 1.41 | -- | 768.69 | -0.0182 | -0.0182 | 0.00009 | 0.0249 | 0.0023 | -- | -- | -- | -42.02 | -41.56 | -47.15 | -50.51 | 100.00 | 92.74 | -17,949.78 | -334.16 | -- | -147.21 | 0.0072 | -- | -4.69 | -18.06 | 75.85 | -- | -- | -- |
| ExpreS2ion Biotech Holding AB | 673.97k | -6.76m | 9.86m | 18.00 | -- | 1.17 | -- | 14.63 | -1.33 | -1.33 | 0.129 | 0.8696 | 0.0821 | -- | 4.87 | 298,730.80 | -82.36 | -63.54 | -113.92 | -75.88 | -132.91 | -1.94 | -1,003.55 | -524.31 | -- | -- | 0.0055 | -- | 43.07 | -0.1561 | 22.94 | -- | 19.90 | -- |
| Coeptis Therapeutics Holdings Inc | 0.00 | -14.91m | 9.89m | 5.00 | -- | 2.44 | -- | -- | -0.5804 | -0.5804 | 0.00 | 0.1197 | 0.00 | -- | -- | 0.00 | -212.70 | -36.90 | -378.58 | -37.81 | -- | -- | -- | -- | -- | -- | 0.349 | -- | -- | -- | 43.40 | -- | -- | -- |
| BLIS Technologies Ltd | 6.40m | 358.70k | 9.94m | 10.00 | 23.73 | 1.56 | 15.26 | 1.55 | 0.0006 | 0.0006 | 0.0091 | 0.009 | 0.8955 | -- | 8.41 | -- | 5.02 | -2.45 | 5.64 | -2.90 | -- | -- | 5.60 | -2.40 | 8.30 | 23.45 | 0.0328 | -- | 12.61 | 6.52 | 147.85 | 11.14 | 34.35 | -- |
| Pila Pharma AB | 126.95k | -861.66k | 10.12m | 1.00 | -- | 17.50 | -- | 79.69 | -0.5304 | -0.5304 | 0.0767 | 0.28 | 0.1513 | -- | 6.11 | 1,463,020.00 | -102.68 | -108.88 | -122.66 | -121.45 | -127.88 | -42.67 | -678.73 | -1,577.64 | -- | -159.47 | 0.104 | -- | -22.21 | -- | 62.92 | -- | -- | -- |
| StenoCare A/S | 550.22k | -2.25m | 10.30m | 9.00 | -- | 3.12 | -- | 18.71 | -1.13 | -1.13 | 0.2674 | 1.22 | 0.1285 | -- | 2.94 | -- | -52.62 | -28.16 | -70.34 | -35.47 | -- | -- | -409.55 | -371.06 | 1.04 | -5.56 | 0.2362 | -- | -16.30 | -- | -7.77 | -- | -- | -- |
| China NT Pharma Group Co Ltd | 926.46k | -4.21m | 10.36m | 16.00 | -- | -- | -- | 11.18 | -0.1819 | -0.7797 | 0.0375 | -1.38 | 0.011 | 5.87 | 0.337 | 494,520.70 | -5.02 | -12.34 | -- | -163.52 | 710.06 | -- | -454.67 | -128.28 | 0.0185 | -- | 64.15 | -- | -- | -58.12 | 33.07 | -- | -46.32 | -- |
Data as of Jul 18 2024. Currency figures normalised to Laboratorio Farmaceutico Erfo SpA's reporting currency: Euro EUR
